Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macropodidae | 1 | 2024 | 2 | 0.910 |
Why?
|
| Finite Element Analysis | 1 | 2024 | 13 | 0.910 |
Why?
|
| Noise | 4 | 2008 | 33 | 0.870 |
Why?
|
| Voice | 3 | 2008 | 7 | 0.840 |
Why?
|
| Chytridiomycota | 4 | 2011 | 4 | 0.840 |
Why?
|
| Sigmodontinae | 6 | 2024 | 12 | 0.830 |
Why?
|
| Bufonidae | 3 | 2011 | 3 | 0.780 |
Why?
|
| Pneumothorax | 1 | 2020 | 49 | 0.650 |
Why?
|
| Bronchoscopy | 1 | 2020 | 86 | 0.650 |
Why?
|
| Glottis | 4 | 2009 | 13 | 0.640 |
Why?
|
| Biopsy | 1 | 2020 | 410 | 0.590 |
Why?
|
| Cystic Fibrosis | 4 | 2023 | 110 | 0.570 |
Why?
|
| Speech, Alaryngeal | 2 | 2008 | 3 | 0.570 |
Why?
|
| Models, Biological | 7 | 2009 | 1143 | 0.570 |
Why?
|
| Hybridization, Genetic | 3 | 2024 | 14 | 0.490 |
Why?
|
| Selection, Genetic | 2 | 2013 | 71 | 0.380 |
Why?
|
| Climate Change | 2 | 2024 | 18 | 0.370 |
Why?
|
| Speech Acoustics | 3 | 2009 | 8 | 0.370 |
Why?
|
| Water | 2 | 2016 | 300 | 0.350 |
Why?
|
| Mating Preference, Animal | 2 | 2024 | 3 | 0.350 |
Why?
|
| Temperature | 1 | 2011 | 295 | 0.330 |
Why?
|
| Dermatomycoses | 1 | 2009 | 13 | 0.320 |
Why?
|
| Biological Evolution | 2 | 2007 | 114 | 0.310 |
Why?
|
| Voice Quality | 1 | 2006 | 3 | 0.270 |
Why?
|
| Phylogeny | 1 | 2007 | 337 | 0.260 |
Why?
|
| Voice Disorders | 1 | 2006 | 4 | 0.260 |
Why?
|
| Phenotype | 2 | 2007 | 1137 | 0.250 |
Why?
|
| Animals | 14 | 2024 | 19649 | 0.230 |
Why?
|
| Ankle | 1 | 2024 | 22 | 0.220 |
Why?
|
| Restless Legs Syndrome | 1 | 2023 | 6 | 0.220 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 110 | 0.220 |
Why?
|
| Perchlorates | 1 | 2023 | 8 | 0.210 |
Why?
|
| Genetic Variation | 2 | 2003 | 357 | 0.210 |
Why?
|
| Locomotion | 1 | 2024 | 111 | 0.210 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 242 | 0.210 |
Why?
|
| Gait | 1 | 2024 | 114 | 0.210 |
Why?
|
| Hordeum | 1 | 2002 | 3 | 0.200 |
Why?
|
| Plant Leaves | 1 | 2002 | 38 | 0.200 |
Why?
|
| Anura | 1 | 2002 | 8 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2023 | 1479 | 0.200 |
Why?
|
| Fungi | 1 | 2002 | 55 | 0.200 |
Why?
|
| Plant Proteins | 1 | 2002 | 81 | 0.190 |
Why?
|
| Polymers | 2 | 2023 | 316 | 0.190 |
Why?
|
| Optogenetics | 1 | 2021 | 22 | 0.190 |
Why?
|
| Reproductive Isolation | 2 | 2024 | 4 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 58 | 0.160 |
Why?
|
| California | 4 | 2017 | 161 | 0.160 |
Why?
|
| Time Factors | 4 | 2020 | 3615 | 0.160 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 110 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 100 | 0.160 |
Why?
|
| Male | 13 | 2024 | 27742 | 0.150 |
Why?
|
| Calcium | 1 | 2021 | 555 | 0.150 |
Why?
|
| Heme Oxygenase-1 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Species Specificity | 3 | 2015 | 329 | 0.140 |
Why?
|
| Quinolones | 1 | 2017 | 27 | 0.140 |
Why?
|
| Analysis of Variance | 2 | 2009 | 589 | 0.140 |
Why?
|
| Sound Spectrography | 2 | 2006 | 11 | 0.140 |
Why?
|
| Body Size | 3 | 2017 | 23 | 0.140 |
Why?
|
| Longevity | 1 | 2017 | 110 | 0.130 |
Why?
|
| Speech Production Measurement | 2 | 2006 | 8 | 0.130 |
Why?
|
| Ecosystem | 3 | 2013 | 38 | 0.130 |
Why?
|
| Lung | 2 | 2020 | 919 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 54 | 0.130 |
Why?
|
| Sebum | 1 | 2016 | 1 | 0.130 |
Why?
|
| Dermatoglyphics | 1 | 2016 | 2 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2017 | 279 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 420 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 347 | 0.120 |
Why?
|
| Disease Progression | 1 | 2020 | 1119 | 0.120 |
Why?
|
| Humans | 15 | 2023 | 59366 | 0.120 |
Why?
|
| Cestode Infections | 1 | 2015 | 1 | 0.120 |
Why?
|
| Protozoan Infections, Animal | 1 | 2015 | 2 | 0.120 |
Why?
|
| Rodent Diseases | 1 | 2015 | 6 | 0.120 |
Why?
|
| Nematode Infections | 1 | 2015 | 11 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2017 | 391 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2016 | 190 | 0.120 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 256 | 0.110 |
Why?
|
| Hydrogels | 1 | 2016 | 110 | 0.110 |
Why?
|
| Adult | 5 | 2023 | 15679 | 0.110 |
Why?
|
| Gene Flow | 1 | 2013 | 6 | 0.110 |
Why?
|
| Genetic Speciation | 1 | 2013 | 4 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 300 | 0.110 |
Why?
|
| Female | 12 | 2024 | 30719 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 1507 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2011 | 240 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 1015 | 0.090 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mycoses | 1 | 2010 | 45 | 0.080 |
Why?
|
| Kidney | 1 | 2012 | 414 | 0.080 |
Why?
|
| Phonation | 1 | 2009 | 2 | 0.080 |
Why?
|
| Wyoming | 1 | 2009 | 2 | 0.080 |
Why?
|
| Water Microbiology | 1 | 2009 | 10 | 0.080 |
Why?
|
| Colorado | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2009 | 245 | 0.080 |
Why?
|
| Geography | 1 | 2007 | 32 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 674 | 0.070 |
Why?
|
| Vocal Cords | 1 | 2007 | 6 | 0.070 |
Why?
|
| Demography | 1 | 2007 | 169 | 0.070 |
Why?
|
| Communication Aids for Disabled | 1 | 2006 | 5 | 0.070 |
Why?
|
| Loudness Perception | 1 | 2006 | 2 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2006 | 32 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 458 | 0.070 |
Why?
|
| Speech | 1 | 2007 | 62 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 734 | 0.060 |
Why?
|
| Prevalence | 2 | 2023 | 1253 | 0.060 |
Why?
|
| Phonetics | 1 | 2006 | 30 | 0.060 |
Why?
|
| Reproduction | 1 | 2024 | 89 | 0.060 |
Why?
|
| Anions | 1 | 2023 | 33 | 0.050 |
Why?
|
| Amphibians | 1 | 2003 | 4 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2003 | 40 | 0.050 |
Why?
|
| Glucan 1,3-beta-Glucosidase | 1 | 2002 | 1 | 0.050 |
Why?
|
| beta-Glucosidase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Chitinases | 1 | 2002 | 10 | 0.050 |
Why?
|
| Sweetening Agents | 1 | 2002 | 21 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 33 | 0.050 |
Why?
|
| Population Density | 1 | 2002 | 11 | 0.050 |
Why?
|
| North Carolina | 1 | 2002 | 68 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2003 | 91 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 105 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 1951 | 0.050 |
Why?
|
| Kinesthesis | 1 | 2002 | 5 | 0.050 |
Why?
|
| Glucans | 1 | 2002 | 63 | 0.050 |
Why?
|
| Perceptual Disorders | 1 | 2002 | 8 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 32 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 356 | 0.050 |
Why?
|
| Orientation | 1 | 2002 | 27 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2002 | 120 | 0.050 |
Why?
|
| Cell Wall | 1 | 2002 | 115 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2021 | 20 | 0.050 |
Why?
|
| Primates | 1 | 2021 | 42 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 297 | 0.050 |
Why?
|
| Algorithms | 1 | 2006 | 974 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2002 | 140 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2002 | 486 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2003 | 192 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 133 | 0.040 |
Why?
|
| Retina | 1 | 2021 | 115 | 0.040 |
Why?
|
| Attention | 1 | 2002 | 146 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 193 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1553 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2003 | 442 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 159 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2017 | 17 | 0.040 |
Why?
|
| Seasons | 1 | 2017 | 123 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 226 | 0.030 |
Why?
|
| Aged | 3 | 2008 | 13405 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 205 | 0.030 |
Why?
|
| Plasma Gases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Wettability | 1 | 2016 | 8 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 19 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2016 | 14 | 0.030 |
Why?
|
| Salts | 1 | 2016 | 15 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2016 | 30 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2016 | 52 | 0.030 |
Why?
|
| Electrodes | 1 | 2016 | 34 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2016 | 92 | 0.030 |
Why?
|
| Touch | 1 | 2016 | 27 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 51 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 105 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 35 | 0.030 |
Why?
|
| Rheology | 1 | 2016 | 71 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 644 | 0.030 |
Why?
|
| Cestoda | 1 | 2015 | 1 | 0.030 |
Why?
|
| Eimeria | 1 | 2015 | 1 | 0.030 |
Why?
|
| Giardia | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cryptosporidium | 1 | 2015 | 5 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 271 | 0.030 |
Why?
|
| Nematoda | 1 | 2015 | 34 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 165 | 0.030 |
Why?
|
| Inbreeding | 1 | 2013 | 5 | 0.030 |
Why?
|
| Chimera | 1 | 2013 | 40 | 0.030 |
Why?
|
| Courtship | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2375 | 0.030 |
Why?
|
| Fertility | 1 | 2013 | 78 | 0.030 |
Why?
|
| Aggression | 1 | 2013 | 52 | 0.030 |
Why?
|
| Middle Aged | 2 | 2008 | 16310 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 1983 | 0.030 |
Why?
|
| Social Behavior | 1 | 2013 | 87 | 0.030 |
Why?
|
| Tobramycin | 1 | 2012 | 6 | 0.020 |
Why?
|
| Colistin | 1 | 2012 | 7 | 0.020 |
Why?
|
| Time | 1 | 2012 | 26 | 0.020 |
Why?
|
| Gentamicins | 1 | 2012 | 23 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 705 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2012 | 163 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 145 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1559 | 0.020 |
Why?
|
| Ions | 1 | 2010 | 52 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 60 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 88 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 100 | 0.020 |
Why?
|
| Air Pressure | 1 | 2009 | 5 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 197 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 10294 | 0.010 |
Why?
|
| Immunity, Active | 1 | 2003 | 10 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 2003 | 60 | 0.010 |
Why?
|
| Animal Diseases | 1 | 2003 | 1 | 0.010 |
Why?
|
| Reproduction, Asexual | 1 | 2003 | 3 | 0.010 |
Why?
|
| Saliva | 1 | 2003 | 99 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 88 | 0.010 |
Why?
|
| Clone Cells | 1 | 2003 | 106 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 2003 | 35 | 0.010 |
Why?
|
| Nucleotides | 1 | 2003 | 44 | 0.010 |
Why?
|
| Heterozygote | 1 | 2003 | 161 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 185 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2003 | 187 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 2002 | 37 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2002 | 228 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 6069 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 248 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2002 | 371 | 0.010 |
Why?
|
| Stroke | 1 | 2002 | 1127 | 0.010 |
Why?
|
| United States | 1 | 2003 | 7426 | 0.010 |
Why?
|